Abstract:Investigating the predictors for lumbar puncture to diagnose the asymptomatic neurosyphilis among HIV and syphilis co-infected patients in Shanghai, China. Respectively, screening the medical records from August 1, 2009 to June 30, 2015. Those HIV-infected patients with concurrent syphilis who had received lumbar puncture were selected and their clinical and demographic data were recorded. Participants comprised symptomatic and asymptomatic patients. The latter ones could be further divided into 3 groups: late syphilis, early syphilis with anti-syphilis treatment failure, and early syphilis with serum toludine red unheated serum test (TRUST) ≥1:32. Both syphilis stage and anti-syphilis treatment effect were defined by common criteria, and syphilis of unknown duration was considered as late syphilis. Asymptomatic neurosyphilis was defined as neurosyphilis without neurological symptoms such as headache, cognitive dysfunction, motor deficits, auditory or ophthalmic abnormalities, and stroke. Neurosyphilis was defined as reactive cerebrospinal fluid (CSF) TRUST and/or CSF white blood cell >20 cells/μL without other reasons. Mann-Whitney test and Fisher's exact test were used for analyzing the difference between neurosyphilis and non-neurosyphilis group. Logistic regression test was performed to analyze the risk factors for neurosyphilis. In total, 170 participants were collected, and the rate of neurosyphilis was 32.35%. Among all the 105 participants without neurological symptoms, 80 patients were with late syphilis and 25 were with early syphilis. Among the early syphilis patients, 23 had a TRUST ≥1:32 and the other 2 experienced an anti-syphilis treatment failure. The differences of clinical and demographic variables between neurosyphilis and non-neurosyphilis group were not statistically significant except the serum TRUST titer (P < 0.01). From HIV/syphilis co-infected patients with or without neurological symptom, those who had neurological symptoms, CD4 <350 per μL and serological TRUST titer ≥1:16 were 4.9-fold (95% confidence interval [CI]: 2.37-10.31), 4.3-fold (95% CI: 1.17-15.78), and 4.1-fold (95% CI: 1.58-10.76), respectively, more likely to be diagnosed with neurosyphilis. Asymptomatic patients whose serum TRUST titer ≥1:16 were 8.48-fold (95% CI: 1.08-66.63) more likely to have asymptomatic neurosyphilis. Among asymptomatic HIV-infected patients with late syphilis or early syphilis experienced an anti-syphilis treatment failure, those who have a serum TRUST titer ≥1:16 are suggested to perform lumbar puncture in order to avoid delayed diagnosis and the occurrence of severe sequelae of syphilis.

Platelet Indices Are the Promising Biomarkers in Monitoring Disease Activities in Patients with Syphilis

Serum Levels of IL-17,IL-23 and ROR-γt in Patients with Secondary Syphilis

Comparing Noninvasive Predictors of Neurosyphilis among Syphilis Patients with and Without HIV Co-Infection Based on the Real-World Diagnostic Criteria: A Single-Center, Retrospective Cohort Study in China.

The dynamic change of IL-4,IL-12,IFN-γ and its relation with the prognosis of syphilis

Platelet Distribution Width As a Novel Indicator of Disease Activity in Systemic Lupus Erythematosus

Exosomal Microrna Profiles from Serum and Cerebrospinal Fluid in Neurosyphilis.

Current Syphilis Infection in Virally Suppressed People Living with HIV: a Cross-Sectional Study in Eastern China

Evaluating the clinical utility of semi-quantitative luciferase immunosorbent assay using Treponema pallidum antigens in syphilis diagnosis and treatment monitoring

Neutrophil-associated Proteins as Novel Biomarkers Elevated in Cerebrospinal Fluid of Neurosyphilis Patients

Increased CCL24 and CXCL7 Levels in the Cerebrospinal Fluid of Patients with Neurosyphilis

Clinical Characteristics, Diagnosis, and Predictors of Neurosyphilis Patients with Human Immunodeficiency Virus Co-Infection

A 4-fold or greater decrease in TPPA titers may indicate effective BPG treatment in primary syphilis

Utility of rapid plasmin reagin titres in assessing treatment response and re-infection for infectious syphilis

Clinical Features of and Factors Correlated with Neurosyphilis in HIV/Syphilis Co-Infected Patients Based on Stage of Syphilis

Syphilis and cardiovascular risk: a Taiwanese registry

Characteristic profiling of soluble factors in the cerebrospinal fluid of patients with neurosyphilis

Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects

Serum TRSUT Titer ≥1

Risk factors associated with prevalent and incident syphilis among an HIV-infected cohort in Northeast China

Clinical Prediction and Diagnosis of Neurosyphilis in HIV-negative Patients: a Case-Control Study

Clinical and laboratory features of neurosyphilis: A single-center, retrospective study of 402 patients